Panacea Acquisition Corp. II
SEC CIK 1828989 · PANA · last insider filing 2023-05-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Nodelman Oleg | Director · CEO and Chairman of the Board | filed 2021 - 2023 |
| Ecor1 Capital Fund, L.P. | Director | filed 2021 - 2023 |
| Ecor1 Capital, LLC | Director | filed 2021 - 2023 |
| Ecor1 Capital Fund Qualified, L.P. | Director | filed 2021 - 2023 |
| Ecor1 Venture Opportunity Fund, LP | Director | filed 2021 - 2023 |
| Biotech Opportunity GP, LLC | Director | filed 2021 - 2023 |
| Ecor1 Panacea Holdings II, LLC | Director | filed 2021 - 2023 |
| Williams Douglas E | Director | filed 2021 - 2021 |
| Kjellson Nina S | Director | filed 2021 - 2021 |
| Giordano Douglas E. | Director | filed 2021 - 2021 |
| Tipirneni Praveen P. | Director | filed 2021 - 2021 |
| Marriott Sarah | Director · Secretary | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Perlen Scott | Chief Financial Officer | filed 2021 - 2021 |
| Stout Caroline | Chief Investment Officer | filed 2021 - 2021 |
| Platshon Scott | Chief Operating Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.